Literature DB >> 9924856

New method to evaluate myocyte remodeling from formalin-fixed biopsy and autopsy material.

A M Gerdes1, T Onodera, T Tamura, S Said, T J Bohlmeyer, W T Abraham, M R Bristow.   

Abstract

BACKGROUND: Excessive lengthening of cardiac myocytes attributed to series addition of sarcomeres is a consistent feature of left ventricular dilation in chronic heart failure. Currently, it is not feasible to assess myocyte dimensions, particularly myocyte length, in a manner that is of potential diagnostic usefulness. METHODS AND
RESULTS: Isolated myocytes from three groups of normal rats (100, 200, and 300 g) were obtained by using two different methods: (1) digestion of formalin-fixed myocardial tissue using potassium hydroxide (KOH) and (2) retrograde aortic perfusion of fresh hearts with collagenase. There was no difference in mean cell length between the two methods. The KOH method was also used to isolate intact, rod-shaped myocytes from formalin-fixed human cadaver left ventricles (control, n = 3; heart failure, n = 3) and from human right ventricle biopsy specimens (n = 6). Confirming our previous work using collagenase-isolated myocytes from fresh human explants, left ventricular myocytes from failing hearts showed longer mean cell length compared with control hearts. Data from human right ventricle biopsy specimens confirmed our previous finding in rats that myocyte lengthening is less pronounced in this chamber in heart failure.
CONCLUSIONS: The KOH method can be used to obtain reliable measurements of myocyte length and other cellular parameters from myocardial biopsies and autopsy material. Such data may be useful in the diagnostic assessment of remodeling associated with heart failure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9924856     DOI: 10.1016/s1071-9164(98)90240-8

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  12 in total

1.  MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice.

Authors:  Denghong Zhang; Riccardo Contu; Michael V G Latronico; Jianlin Zhang; Jian Ling Zhang; Roberto Rizzi; Daniele Catalucci; Shigeki Miyamoto; Katherine Huang; Marcello Ceci; Yusu Gu; Nancy D Dalton; Kirk L Peterson; Kun-Liang Guan; Joan Heller Brown; Ju Chen; Nahum Sonenberg; Gianluigi Condorelli
Journal:  J Clin Invest       Date:  2010-07-19       Impact factor: 14.808

2.  Overexpression of bone morphogenetic protein 10 in myocardium disrupts cardiac postnatal hypertrophic growth.

Authors:  Hanying Chen; Weidong Yong; Shuxun Ren; Weihua Shen; Yongzheng He; Karen A Cox; Wuqiang Zhu; Wei Li; Mark Soonpaa; R Mark Payne; Diego Franco; Loren J Field; Vicki Rosen; Yibin Wang; Weinian Shou
Journal:  J Biol Chem       Date:  2006-06-23       Impact factor: 5.157

3.  Mechanism of origin of conduction disturbances in aging human atrial bundles: experimental and model study.

Authors:  Madison S Spach; J Francis Heidlage; Paul C Dolber; Roger C Barr
Journal:  Heart Rhythm       Date:  2006-11-01       Impact factor: 6.343

4.  Caspase inhibition modulates left ventricular remodeling following myocardial infarction through cellular and extracellular mechanisms.

Authors:  William M Yarbrough; Rupak Mukherjee; Robert E Stroud; Evan C Meyer; G Patricia Escobar; Jeffrey A Sample; Jennifer W Hendrick; Joseph T Mingoia; Francis G Spinale
Journal:  J Cardiovasc Pharmacol       Date:  2010-04       Impact factor: 3.105

5.  TNF-alpha inhibition attenuates adverse myocardial remodeling in a rat model of volume overload.

Authors:  Lynetta J Jobe; Giselle C Meléndez; Scott P Levick; Yan Du; Gregory L Brower; Joseph S Janicki
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-07       Impact factor: 4.733

6.  Temporal evaluation of cardiac myocyte hypertrophy and hyperplasia in male rats secondary to chronic volume overload.

Authors:  Yan Du; Eric Plante; Joseph S Janicki; Gregory L Brower
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

7.  Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats.

Authors:  Giselle C Meléndez; Jennifer L McLarty; Scott P Levick; Yan Du; Joseph S Janicki; Gregory L Brower
Journal:  Hypertension       Date:  2010-07-06       Impact factor: 10.190

Review 8.  Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair.

Authors:  Matthew E Hartman; Dao-Fu Dai; Michael A Laflamme
Journal:  Adv Drug Deliv Rev       Date:  2015-05-14       Impact factor: 15.470

9.  Cardiac restricted overexpression of kinase-dead mammalian target of rapamycin (mTOR) mutant impairs the mTOR-mediated signaling and cardiac function.

Authors:  Wei-Hua Shen; Zhuang Chen; Shu Shi; Hanying Chen; Wuqiang Zhu; Anne Penner; Guixue Bu; Wei Li; David W Boyle; Michael Rubart; Loren J Field; Robert Abraham; Edward A Liechty; Weinian Shou
Journal:  J Biol Chem       Date:  2008-03-07       Impact factor: 5.157

10.  Histologically measured cardiomyocyte hypertrophy correlates with body height as strongly as with body mass index.

Authors:  Richard E Tracy; Gary E Sander
Journal:  Cardiol Res Pract       Date:  2011-06-08       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.